Bullstory
May 28, 2026

E-commerce competition in pharmaceuticals heats up as first 'medicinal jelly' set to launch

E-commerce competition in pharmaceutical distribution is expanding. A chewable medicinal jelly that can be taken without water is set to launch in South Korea, alongside news of robots shifting to mass production and strong earnings from Snowflake.


E-commerce competition in pharmaceuticals heats up as first 'medicinal jelly' set to launch

E-commerce competition is intensifying in the pharmaceutical distribution market. Platforms based on online pharmacies are expanding their market entry, focusing on delivery and price competition. Some companies have announced plans to strengthen their links with pharmacies and their logistics systems.

A medicinal jelly that can be chewed without water is set to be commercialized in South Korea. The manufacturer said it would launch the product with a focus on ease of use. The product is being presented as a new way of taking medicine, with a formulation different from conventional tablets.

Robotics technology is moving beyond the research lab, with adoption in industrial settings accelerating. Companies are making the establishment of mass-production systems a key priority. They are expanding the use of production automation equipment and standardizing production processes.

Robots taking on workers’ roles in factories still face the challenge of ensuring safety and reliability. Efforts are underway to strengthen safety testing and on-site validation procedures. Operating manuals and certification preparations are also in progress to ensure consistent quality.

Cloud data platform Snowflake recently reported results that exceeded expectations. The company said key cloud partnerships contributed to its growth. Demand for related services is drawing attention as a result.

International competition is pronounced in the humanoid robot sector. China is focusing on expanding production volumes, while the United States is emphasizing technical standards and safety regulations. Supply expansion and regulatory barriers are advancing at the same time.

Sources: 국내언론,매일경제 증권,연합뉴스 경제

Bullstory synthesized this report from the linked sources. AI may have assisted the writing process. Check the original reports for factual confirmation.